ARS Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,605	1,025	526	800	-	-
Market Cap Growth	25.16%	94.90%	-34.23%	-	-	-
Enterprise Value	1,400	821	284	839	-	-
Last Close Price	16.75	10.55	5.48	8.53	-	-
PE Ratio	-	128.20	-	-	-	-
PS Ratio	16.79	11.50	17535.50	607.80	-	-
PB Ratio	7.18	3.99	2.28	2.93	-	-
P/TBV Ratio	7.25	4.12	2.29	2.93	-	-
P/FCF Ratio	-	78.96	-	-	-	-
P/OCF Ratio	-	75.68	-	-	-	-
EV/Sales Ratio	14.41	9.21	9483.00	637.20	-	-
EV/FCF Ratio	-	63.20	-	-	-	-
Debt / Equity Ratio	0.30	0.27	0.00	0.00	0.20	1.40
Debt / FCF Ratio	-	5.35	-	-	-	1.10
Asset Turnover	0.35	0.31	0	0.01	0.13	-
Quick Ratio	10.35	13.79	95.80	50.59	7.34	3.03
Current Ratio	11.00	14.26	96.92	51.01	7.42	3.21
Return on Equity (ROE)	-6.91%	3.28%	-21.59%	-21.84%	-77.93%	-
Return on Assets (ROA)	-6.10%	-0.66%	-16.40%	-12.56%	-27.68%	-
Return on Capital (ROIC)	-6.48%	-0.69%	-16.73%	-13.17%	-34.25%	-
Earnings Yield	-0.97%	0.78%	-10.33%	-4.34%	-	-
FCF Yield	-1.31%	1.27%	-11.30%	-5.04%	-	-
Buyback Yield / Dilution	-1.62%	-7.54%	-138.30%	-38.39%	-42.81%	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q